Encompass Health Corp [EHC] Investment Appeal on the Rise

Encompass Health Corp’s recently made public that its EVP, Chief Operating Officer Tuer Patrick William unloaded Company’s shares for reported $0.13 million on Aug 27 ’25. In the deal valued at $123.59 per share,1,020 shares were sold. As a result of this transaction, Tuer Patrick William now holds 18,846 shares worth roughly $2.33 million.

Then, Patrick Tuer bought 1,020 shares, generating $126,062 in total proceeds.

Before that, Tarr Mark J sold 118,384 shares. Encompass Health Corp shares valued at $14,387,152 were divested by the President & CEO at a price of $121.53 per share. As a result of the transaction, Tarr Mark J now holds 527,070 shares, worth roughly $65.2 million.

KeyBanc Capital Markets initiated its Encompass Health Corp [EHC] rating to an Overweight in a research note published on October 11, 2024; the price target was $115. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in early July with a ‘”an Outperform”‘ rating. Barclays began covering EHC with “an Overweight” recommendation on March 06, 2024. Barclays started covering the stock on March 14, 2023. It rated EHC as “an Equal weight”.

Price Performance Review of EHC

On Tuesday, Encompass Health Corp [NYSE:EHC] saw its stock jump 1.59% to $123.7. Over the last five days, the stock has gained 1.24%. Encompass Health Corp shares have risen nearly 35.12% since the year began. Nevertheless, the stocks have risen 33.95% over the past one year. While a 52-week high of $124.67 was reached on 08/21/25, a 52-week low of $87.85 was recorded on 01/03/25.

Levels Of Support And Resistance For EHC Stock

The 24-hour chart illustrates a support level at 122.19, which if violated will result in even more drops to 120.67. On the upside, there is a resistance level at 124.46. A further resistance level may holdings at 125.22.

How much short interest is there in Encompass Health Corp?

A steep rise in short interest was recorded in Encompass Health Corp stocks on 2025-08-15, growing by 40026.0 shares to a total of 1.03 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 0.99 million shares. There was a rise of 3.89%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on September 24, 2021 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $98 price target.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.